Aluminium and bone disease in chronic renal failure

Nephrology Dialysis Transplantation

Volumn 17, Issue SUPPL. 2, 2002, Pages 21-24

  Malluche, Hartmut H ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Accumulation; Aluminium; Bone; Mineralization; Osteodystrophy; Osteomalacia

Indexed keywords

ALUMINUM; BIOLOGICAL MARKER; DEFEROXAMINE; PHOSPHATE BINDING AGENT; SEVELAMER;

ARTICLE; BLOOD LEVEL; BONE BIOPSY; BONE GROWTH; BONE METABOLISM; BONE MINERALIZATION; CHELATION THERAPY; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CORRELATION FUNCTION; DIALYSIS; HEAVY METAL POISONING; HISTOPATHOLOGY; HUMAN; INTESTINE ABSORPTION; METABOLIC BONE DISEASE; OSTEOMALACIA; PRIORITY JOURNAL; RENAL OSTEODYSTROPHY; TISSUE LEVEL; URINARY EXCRETION;

EID: 0036230925     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/17.suppl_2.21     Document Type: Article

References (26)

1. The dialysis encephalopathy syndrome. Possible aluminum intoxication
2. Aluminum-related bone disease in mild and advanced renal failure: Evidence for high prevalence and morbidity and studies on etiology and diagnosis
3. Trends in renal osteodystrophy: A survey from 1983 to 1995 in a total of 2248 patients
4. Renal bone disease 1990: An unmet challenge for the nephrologist
5. Loss of bone resulting from accumulation of aluminum in bone of patients undergoing dialysis
6. Stainable aluminum and not aluminum content reflects bone histology in dialyzed patients
7. Aluminum intoxication of bone in renal failure-fact or fiction?
8. Aluminum-related bone disease
9. The role of bone biopsy in the management of patients with renal osteodystrophy
10. Aluminum deposition at the osteoid-bone interface. An epiphenomenon of the osteomalacic state in vitamin D-deficient dogs
11. Die Aetiologie der Tuberculose
12. Aluminum: Toxin or innocent bystander in renal osteodystrophy
13. Tissue and cellular basis for impaired bone formation in aluminum-related osteomalacia in the pig
14. Transferrin enhances the antiproliferative effect of aluminum on osteoblast-like cells
15. Bone disease and aluminum: Pathogenic considerations
16. Oral aluminum administration to uremic, hyperparathyroid, or vitamin D-supplemented rats
17. Calcitriol, parathyroid hormone, and accumulation of aluminum in bone in dogs with renal failure
18. Effect of aluminium load on parathyroid hormone synthesis
19. Aluminum: Effects on bone and role in the pathogenesis of renal osteodystrophy
20. Reconsidering the importance of long-term low-level aluminum exposure in renal failure patients
21. Diagnosis and treatment of aluminium bone disease
22. Treatment of aluminium intoxication: A new scheme for desferrioxamine administration
23. RenaGel, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone
24. Long-term effects of sevelamer hydrochloride on the calcium × phosphate product and lipid profile of haemodialysis patients
25. Effects of silicon, citrate and the fasting state on the intestinal absorption of aluminium in rats
26. 26A1